Clinical Trial Update: A Safety Study to Compare the Effect of Two PrEP-001 Nasal Powder Formulations on Nasal Mucosa and Serum Cytokine Production [Phase 1]

View source ↗

Summary

A Phase 1 safety study comparing two PrEP-001 nasal powder formulations to assess effects on nasal mucosa and serum cytokine responses in participants with uppe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Respiratory Tract Infection

Drugs mentioned

• PrEP-001

Snippet

Sponsor: Prep Biopharm Limited | Conditions: Upper Respiratory Tract Infections | Phase 1 | Status: COMPLETED